Prognostic value of the combination of circulating tumor cells plus kras in patients with metastatic colorectal cancer treated with chemotherapy plus bevacizumab

  1. Sastre, J.
  2. Vidaurreta, M.
  3. Gómez, A.
  4. Rivera, F.
  5. Massutí, B.
  6. López, M.R.
  7. Abad, A.
  8. Gallen, M.
  9. Benavides, M.
  10. Aranda, E.
  11. Rubio, E.D.
Revue:
Clinical Colorectal Cancer

ISSN: 1533-0028 1938-0674

Année de publication: 2013

Volumen: 12

Número: 4

Pages: 280-286

Type: Article

DOI: 10.1016/J.CLCC.2013.06.001 GOOGLE SCHOLAR